<?xml version="1.0" ?><ns2:com.thomsonreuters.ls.service.contract.soap.trials.v2.TrialResultsOutput xmlns:ns2="local" hits="1" offset="0" totalResults="1"><SearchResults><Trial Id="348434"><Indications><Indication>Macular edema</Indication><Indication>Retinal venous occlusion</Indication></Indications><CompaniesSponsor><Company>Nagoya City University</Company></CompaniesSponsor><Countries><Country>Japan</Country></Countries><DateChangeLast>2018-08-06T00:00:00Z</DateChangeLast><DateStart>2017-11-30T00:00:00Z</DateStart><Identifiers><Identifier>UMIN000033595</Identifier></Identifiers><PatientCountEnrollment>30</PatientCountEnrollment><Phase>Phase Not Applicable</Phase><RecruitmentStatus>Completed</RecruitmentStatus><Teaser>The objective of the study was to classify retinal microaneurysms morphologically in eyes with branch retinal vein occulusion and investigate the frequency of occurrence, the risk factors, and the relationship with macular edema.</Teaser><TrialCategories><Category>Biological</Category></TrialCategories><EndpointIndex><EndpointIndex>Macular edema - Assessment of Disease Relapse/Recurrence</EndpointIndex><EndpointIndex>Macular edema - Assessment of ocular function</EndpointIndex><EndpointIndex>Macular edema - Protocol Specified Other Endpoints</EndpointIndex><EndpointIndex>Macular edema - Protocol Specified Other Endpoints - Other Laboratory assessment</EndpointIndex><EndpointIndex>Other ocular disease - Clinical Assessments</EndpointIndex></EndpointIndex><TermsPatientSelection><Term>Young Adults (18-44 yrs)</Term><Term>Middle-aged Adults (45-64 yrs)</Term><Term>Aged Adults (65-79 yrs)</Term><Term>Elderly Adults (80 and over)</Term><Term>Japanese Ancestry</Term></TermsPatientSelection><TitleDisplay>Evaluation of relationship between retinal microaneurysm and macular edema in eyes with BRVO</TitleDisplay><PatientSegmentTerms><PatientSegment>Macular edema - Subjects with Cystoid Macular Edema - Subjects with retinal vein occlusion(RVO) associated macular edema</PatientSegment><PatientSegment>Other ocular disease - Subjects with specific disease</PatientSegment></PatientSegmentTerms><BiomarkerNames><BiomarkerName>Retina</BiomarkerName></BiomarkerNames><PrimaryCompletionDate></PrimaryCompletionDate><NumberOfSites>1</NumberOfSites><ContactNames><Name>Yoshio Hirano</Name></ContactNames></Trial></SearchResults></ns2:com.thomsonreuters.ls.service.contract.soap.trials.v2.TrialResultsOutput>